Tirzepatide + HRT: Tony Huge’s Take on Enhanced Weight Loss
Recent groundbreaking research has revealed a compelling connection between menopausal hormone therapy (HRT) and enhanced weight loss outcomes when combined with tirzepatide, offering new insights into hormonal optimization strategies that align with principles long advocated by Tony Huge and the biohacking community. This development represents a significant advancement in understanding how strategic hormone manipulation can […]
Retatrutide And The Glucagon Receptor: The Genetics 23andMe Didn’t Reach
TL;DR Retatrutide is a triple agonist hitting GLP-1, GIP, AND glucagon receptors — the third axis that tirzepatide doesn’t touch and 23andMe’s April 2026 paper didn’t analyze. Primary mechanism: Glucagon receptor (GCGR) activation adds hepatic gluconeogenesis suppression + thermogenic signaling on top of the glp-1/GIP metabolic reprogramming. TRIUMPH-4 numbers: 28.7% mean weight loss at 12mg […]
GLP-1 Pharmacogenomics: The 23andMe Variants That Predict Tirzepatide Side Effects
TL;DR April 2026 Nature paper from 23andMe Research Institute identifies two missense variants — GLP1R rs10305420 (p.Pro7Leu) and GIPR rs1800437 (p.Glu354Gln) — that predict tirzepatide side effects with 14.8x odds ratio for vomiting in double homozygotes. Primary mechanism: Pro7Leu shifts glp-1 receptor signaling bias toward beta-arrestin recruitment (nausea pathway) vs. cAMP (therapeutic pathway); GIPR variant […]
GLP-1 Agonists Then And Now: From Liraglutide With Coach Trevor To LLY’s Quintuple Agonist
TL;DR What it is: Evolution from single glp-1 agonists (liraglutide, semaglutide) to Lilly’s 2026 quintuple agonist targeting GLP-1, GIP, glucagon, amylin, and PYY receptors simultaneously Primary mechanism: Multi-pathway appetite suppression, enhanced insulin sensitivity, direct lipolysis activation, and metabolic rate elevation through independent receptor cascades Who it’s for: Enhanced Men pursuing longevity escape velocity who want […]
Ozempic Muscle Loss: Tony Huge’s Take on GLP-1 Body Composition
The bodybuilding and biohacking community has been buzzing with concerning reports about a major side effect of the popular weight loss drug Ozempic: significant muscle mass loss. Recent coverage from Vox highlights how users are becoming increasingly alarmed as they watch their hard-earned muscle disappear along with unwanted fat. For those in the performance enhancement […]
GLP-1 Semaglutide Muscle Loss: Tony Huge Community Alert
A concerning development in the peptide and weight management space has emerged that demands immediate attention from the bodybuilding and biohacking community. Recent research published in Genetic Engineering and Biotechnology News reveals that semaglutide, the popular glp-1 receptor agonist, may be linked to reduced muscle strength in laboratory studies. This finding has significant implications for […]
GLP-1 Weight Loss Drugs & Muscle Preservation: Analysis
The fitness and bodybuilding community is buzzing with concerns about muscle loss associated with popular GLP-1 weight loss medications like Ozempic and Wegovy. A recent analysis from McMaster University has reignited the debate over whether muscle preservation during glp-1 therapy represents a significant challenge or an overblown concern for physique athletes and bodybuilders. For followers […]
Lilly Halts Muscle-Sparing Obesity Drug: What It Means for Bodybuilders
The pharmaceutical landscape took a surprising turn when eli lilly announced the discontinuation of its promising muscle-sparing obesity drug trial, sending ripples through the bodybuilding and biohacking communities. According to recent reports from BioPharma Dive, this development marks a significant setback in the quest for pharmaceutical solutions that can achieve fat loss while preserving lean […]
GLP-1 Muscle Loss Concerns: What Tony Huge’s Community Needs to Know
The bodybuilding and biohacking community has been buzzing with concerns about glp-1 receptor agonists and their potential impact on muscle mass. However, recent medical insights suggest that fears surrounding GLP-1 muscle loss may be significantly overblown, according to a new report from MDLinx. This development has important implications for Tony Huge’s audience, particularly those exploring […]
Ozempic Muscle Loss: Tony Huge’s Take on Better Alternatives
Recent findings reported by FOX 2 have sent shockwaves through the fitness and bodybuilding community, revealing that popular weight loss drug Ozempic often leads to disproportionate muscle loss compared to fat reduction. This concerning development has significant implications for anyone serious about body composition, muscle preservation, and optimal health outcomes. For followers of Tony Huge’s […]